Production (Stage)
STAAR Surgical Company
STAA
$18.68
-$0.09-0.48%
NASDAQ
| 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -564.64% | -194.66% | 6.99% | -35.61% | -53.32% |
| Total Depreciation and Amortization | 52.47% | 34.48% | 8.12% | 5.46% | 13.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.70% | 18.93% | 2.58% | 17.10% | 41.43% |
| Change in Net Operating Assets | 173.78% | 86.77% | 84.82% | 64.97% | 59.07% |
| Cash from Operations | -128.26% | 7.75% | 426.64% | 137.65% | 17.42% |
| Capital Expenditure | 4.05% | -28.62% | -8.53% | -46.25% | -10.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -120.17% | -138.71% | -85.89% | 165.46% | 180.59% |
| Cash from Investing | -149.69% | -179.65% | -431.29% | 138.74% | 156.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.03% | -2.48% | -1.23% | 1.23% | -6.00% |
| Issuance of Common Stock | -83.09% | -23.56% | -18.36% | 83.46% | 79.93% |
| Repurchase of Common Stock | -5.55% | 28.23% | 33.35% | 23.94% | 20.12% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -94.39% | -22.81% | -14.47% | 127.62% | 112.38% |
| Foreign Exchange rate Adjustments | 115.03% | -650.00% | 445.30% | -322.67% | -59.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -137.98% | -140.26% | 2,120.50% | 190.99% | 230.03% |